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Abstract  25 
Background:  Adults being investigated for tuberculosis (TB) in South Africa experience high mortality, 26 
yet causes of death (CoD) are not well defined. We determined CoD in this population using verbal 27 
autopsy (VA), and compared HIV- and TB-associated  CoD using physician-certified verbal autopsy 28 
(PCVA) and InterVA-4 software.  29 
Methods: Cross-sectional study. All contactable consenting caregivers of participants who died during a 30 
trial comparing Xpert MTB/RIF to smear microscopy were interviewed using the World Health 31 
Organization VA tool. CoD were assigned using PCVA and InterVA-4. Kappa statistic(K) and concordance 32 
correlation coefficient (CCC) were calculated for comparison. 33 
Results: Among 231 deaths, relatives of 137 deceased were interviewed. Of the 137 deceased 34 
(76[55.4%] males, median age 41 years [interquartile range 33-50]). PCVA assigned 70(51.1%) TB 35 
immediate CoD (44[62.8%] pulmonary TB; 26[37.1%] extra-pulmonary TB); 21(15.3%) HIV/AIDS-related; 36 
and 46(33.5%) other CoD. InterVA-4 assigned 48 (35.0%) TB deaths; 49(35.7%) HIV/AIDS-related deaths; 37 
and 40(29.1%) other CoD. Agreement between PCVA and InterVA-4 CoD was slight at individual level (K 38 
=0.20; 95% confidence interval [CI] 0.10-0.30) and poor at population level (CCC 0.67; 95% CI 0.38 - 39 
0.99). 40 
Conclusion: TB and HIV are leading CoD among adults being investigated for TB. PCVA and InterVA 41 
agreement at individual level was slight and poor at population level. VA methodology needs further 42 
development where TB and HIV are common. 43 
  44 
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Introduction  45 
Tuberculosis (TB) is a leading cause of death (CoD) in South Africa1 and is a public health priority, with an 46 
estimated 380,0002  cases in 2013, among whom 62% were also living with human immunodeficiency 47 
Virus (HIV).3 The World Health Organization (WHO) has set global targets to reduce TB mortality by 75% 48 
in 2025 compared to 2015 figures as a baseline.2 To track the reduction in TB mortality, accurate data on 49 
numbers of TB deaths are needed. CoD is most accurately assigned using pathological autopsy.4 50 
However, pathological autopsies are logistically difficult and rarely performed. In areas where not all 51 
deaths occur in health facilities and CoD are not determined, poor vital statistics, as well as the need to 52 
better understand the distribution of CoD at population level, have led to verbal autopsy (VA) being 53 
used to estimate CoD. This involves interviewing caregivers about the signs, symptoms, medical history, 54 
and circumstances surrounding the individual’s death.5 VA interview data can be interpreted to estimate 55 
CoD using methods such as physician-certified verbal autopsy (PCVA) and computer-coded verbal 56 
autopsy (CCVA), with PCVA being the most widely used method. CCVA uses software that employs 57 
algorithms and probabilistic methods (including InterVA-4), while the PCVA method involves at least two 58 
physicians examining each record and attempting to reach a consensus on CoD using codes from the 59 
10th version of the International Classification of Diseases (ICD-10).6,7  60 
 61 
The XTEND trial, a pragmatic cluster-randomised trial embedded in the South African national roll-out of 62 
Xpert MTB/RIF, compared mortality over six months among adults investigated for TB using Xpert 63 
MTB/RIF vs. smear microscopy as the initial diagnostic test.8 XTEND found high mortality in adults being 64 
investigated for TB, with no difference in mortality at six months between the study arms.8 The cohort 65 
of XTEND participants who died, presented a unique opportunity to evaluate VA methodologies in a 66 
cohort with high TB/HIV prevalence. The aim of this paper was to:  use VA to assign CoD, among adults 67 
being investigated for TB with a particular interest in TB, and to compare CoD assigned by PCVA to that 68 
assigned by a CCVA method (InterVA-4 ).    69 
 70 
 71 
 72 
 73 
 74 
 75 
 76 
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Methods 77 
XTEND study  78 
The parent XTEND trial is described in detail elsewhere.8 Between June and November 2012, a 79 
representative sample of 4656 consenting participants who were ≥18 years, planning to live in the study 80 
catchment area for more than 8 months, identified by clinic staff as needing investigation for TB and 81 
providing sputum for TB testing were enrolled into the study. At enrolment, participants provided 82 
contact details and those of close relatives or friends. Vital status was ascertained  by contacting 83 
participants, their next of kin or friends by telephone and, if necessary, conducting home visits. Vital 84 
status of participants was further ascertained by reviewing the Department of Home Affairs vital 85 
statistics register.  86 
Verbal autopsy  87 
All XTEND participants who died during the study were eligible for the VA sub-study, including some who 88 
died more than six months post-enrolment and hence did not contribute to the XTEND primary 89 
outcome. Demographic details and past medical history of deceased participants were extracted from 90 
the XTEND database, but were not available to staff doing VA interviews nor to physicians assigning CoD.  91 
The XTEND database also included case note reviews where TB treatment start dates and antiretroviral 92 
treatment(ART) start dates were obtained. Caregivers, defined as a relative or friend closely associated 93 
with the participant at time of death, were invited to participate by telephonic contact, or if 94 
unsuccessful, home visit. Lay counsellors, trained in  administering the standardized 2012 WHO VA tool 95 
and in grief counselling, administered the questionnaire. The tool comprised of closed questions with 96 
‘yes’, ‘no’, or ‘don’t know’ responses and a narrative section. The caregiver recounted the events leading 97 
up to the participant’s death, detailing information about the deceased’s signs, symptoms, medical 98 
history, and circumstances preceding death in the narrative section.5 Time from enrolment to death was 99 
defined as period from enrolment to date of death. Time from enrolment to TB treatment initiation was 100 
the period from enrolment to date of TB treatment initiation and time from enrolment to ART initiation 101 
was the period from enrolment to date of ART initiation. 102 
 103 
 104 
 105 
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Interpretation of verbal autopsies using PCVA  106 
PCVA involved two physicians independently assigning immediate and underlying CoD using ICD-10 107 
guidelines, based on VA data, including the caregiver’s narrative for each decedent. Where different 108 
immediate or underlying CoD were assigned by the physicians, a consensus meeting was held; if no 109 
consensus was reached, the case was referred to a third independent physician. If still no consensus was 110 
reached, the case was classified “indeterminate”. Physicians were aware that all decedents were 111 
participants in the XTEND trial and had been investigated for TB. For individual CoD analysis, the 112 
following ICD-10 codes were considered to be HIV-related deaths: B20 (HIV resulting in infectious and 113 
parasitic diseases), B21 (HIV disease resulting in malignant neoplasms), B22 (HIV disease resulting in 114 
other specified diseases), B23 (other conditions associated with HIV), and B24 (unspecified HIV disease). 115 
ICD-10 codes A15 (respiratory tuberculosis, bacteriologically and histologically confirmed) and A16 116 
(respiratory tuberculosis, not confirmed bacteriologically or histologically) were categorized as 117 
pulmonary TB (PTB) while A17 (TB of nervous system), A18 (TB of other organs), and A19 (miliary TB) as 118 
extra-pulmonary TB (EPTB). 9  Individual CoD assigned by PCVA were processed further using mortality 119 
medical data system (MMDS) software, which generates underlying CoD from multiple CoD.10 The 120 
output generated by MMDS was categorised into WHO 2012 VA causes of death groups; cause specific 121 
mortality fractions (CSMFs) were calculated by dividing the number of deaths assigned to a group by the 122 
total number of deaths. 5,10  123 
Interpretation of verbal autopsies using InterVA-4 124 
InterVA version 4.03 RC1 (InterVA-4, www.interva.net) is software that uses Bayesian probabilistic 125 
theory to assign CoD. The software generates up to three probable CoD for each case based on a pre-126 
determined algorithm with the CoD assigned the highest likelihood being referred to as the most 127 
probable CoD .11, 12,13 VA data were imported into InterVA-4, set at high HIV and low malaria prevalence 128 
for our study setting. InterVA-4 assigns only PTB as a TB-related cause of death, classifying all EPTB as 129 
“other unspecified infectious diseases”.  Specificity of InterVA-4 in assigning HIV-related CoD has 130 
previously been reported to be 90.1% (95% confidence interval [CI] 88.7-91.4%)14 . The probable CoD 131 
generated for each individual were further processed to generate population CSMFs. 132 
Comparing InterVA-4 and PCVA   133 
The two methods assign a wide range of CoD but for this study we concentrated on HIV/AIDS- and TB-134 
related deaths. At individual level, we focused on the most probable CoD assigned by InterVA-4, 135 
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compared with underlying CoD generated by MMDS for PCVA. For TB deaths, we compared PTB deaths 136 
assigned by PCVA and  by InterVA-4. For HIV deaths, ICD-10 codes (B20-24) assigned by physicians were 137 
grouped together and compared with HIV/AIDS related deaths assigned by InterVA-4.  For individual 138 
CoD assigned, the level of agreement between the two methods was estimated using Cohen’s kappa (Κ) 139 
statistic with a 95% CI. Κ=1 would indicate perfect agreement, and  Κ=0 would indicate agreement no 140 
better than chance.15 Cause specific mortality fractions generated by the two methods were compared 141 
using Lin’s concordance correlation coefficient (CCC) which ranges from -1 to +1  with +1 being perfect 142 
agreement and 0 showing no agreement.16 All analyses were done using Stata (version 13, Stata Corp LP, 143 
College Station, Texas).   144 
Results  145 
231 XTEND participants died between 08 June 2012 and 31  June 2013. From 1 August to 29 November 146 
2013, 231 interviews were attempted with caregivers. Of these 138 (60.0%)were completed; 68 (29.4%) 147 
caregivers could not be traced and 25 (10.8%) refused to be interviewed. Interviews were conducted 148 
within median time of 11 months (interquartile range [IQR] 8-12 months) after deaths had occurred. 149 
One interview was excluded due to a missing narrative section leaving 137 for analysis. Among the 137 150 
decedents, 76 (55.4%) were male and the median age was 41 years (IQR 33-50).  Ninety-seven (70.8%) 151 
had self-reported being HIV-positive with median self-reported CD4 count 118 (IQR 52-290) cells/L. 152 
Baseline characteristics of those who were included were similar to those who were not included except 153 
for number of TB symptoms reported at enrolment (Table 1).  Furthermore there was no difference in 154 
time from enrolment to death between the two groups. A total of 41 participants were started on TB 155 
treatment and 28 (20.4%) had a VA done. Median time from enrolment to TB treatment was 11 days 156 
(IQR 7-33) in those with a VA versus 15 days (IQR 5-30) in those without a VA; this was not different 157 
between the two groups.   A total of 162 participants self-reported being HIV positive in the study and 158 
61(37.6%) had evidence of being initiated on ART. Of the 61, 35 (57.4%) started ART after enrolment 159 
into XTEND. Median time from enrolment to ART treatment initiation was not different between the 160 
groups (Table 1).  161 
 162 
PCVA-assigned CoD 163 
PCVA assigned immediate and underlying CoD for 134 (98.0%) VAs; three (2.2%) VAs were 164 
indeterminate (Table 2). Of the 134 with a CoD, 95 (70.9%) were assigned without requiring a consensus 165 
meeting and 39 (28.5%) after a consensus meeting. Among the 137 decedents, the most common 166 
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immediate CoD assigned was TB (70 decedents [51.1%]). Of these 70 TB deaths, 44 (62.8%) were 167 
attributed to PTB, of which 8 (18.2%) were classified as bacteriologically confirmed as reported on VA. 168 
EPTB was assigned as CoD in 26/70 (37.1%) TB deaths. Of these, 11 (42.3%) were TB of the nervous 169 
system, 10 (38.4%) miliary TB and five (19.2%) TB of other organs. 57/70 ( 81.4%) of those assigned an 170 
immediate TB CoD were assigned an underlying HIV CoD by the physicians.  HIV/AIDS-related immediate 171 
CoD were assigned in 21 (15.3%) decedents; gastrointestinal diseases in seven (5.1%) decedents; 172 
pneumonia in five (3.6 %); cardiac disease and respiratory ailments in four (3.0%) each; renal failure and 173 
malignant neoplasm in three (2.0%) each; while liver disease and intentional self-harm were in two 174 
(1.5%) each (Table 2).  Cause specific mortality fractions were calculated after PCVA CoD were processed 175 
by MMDS software: HIV/AIDS-related deaths accounted for 66.4% of PCVA deaths; PTB for 9.5%; cardiac 176 
disease for 2.9%; and malignant neoplasms, gastrointestinal diseases and accident/self harm for 2.2% 177 
each (Table 3). 178 
 179 
InterVA-assigned CoD 180 
InterVA-4 assigned CoD to 136 (99.2%) decedents; one (0.7%) was classified as indeterminate. 48/137  181 
(35.0%) individuals were assigned a most probable CoD of PTB, 49 (35.7%) an HIV/AIDS-related CoD, and 182 
14 (10.2.%) a malignancy-related CoD. Only one decedent was assigned an “other unspecified infectious 183 
diseases” CoD by InterVA-4 (Table 2).  InterVA-4 assigned 16 decedents with more than one CoD, 13 184 
were assigned two CoD and three were assigned three CoD. Of the 16 with more than one CoD, three 185 
(18.7%) had HIV as a less probable CoD and four (25.0%) had TB as less probable CoD. Only one 186 
decedent with a most probable CoD of PTB had HIV assigned as a less probable CoD and also one with 187 
HIV as a most probable CoD had PTB assigned as a less probable CoD. InterVA-4 CSMFs were calculated 188 
using all assigned CoD: PTB accounted for 33.2% of deaths; HIV/AIDS for  32.8%; malignant neoplasms 189 
for 9.6%; and respiratory ailments for 4.9% (Table 3). 190 
 191 
Comparing InterVA-4 and PCVA CoD 192 
A direct comparison of the single underlying  CoD assigned by MMDS for PCVA and the most probable 193 
CoD assigned by InterVA-4 showed agreement in 65/137 (47.4%) decedents with kappa statistic 0.20 194 
(95% CI 0.10-0.30); representing slight agreement (Table 4).  Comparison of CSMFs assigned by PCVA 195 
and InterVA showed a CCC of 0.67 (95% CI 0.38 - 0.97), which was poor (Table 3). 196 
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Discussion 197 
The XTEND study is the largest cohort to date of adults being investigated for TB. In this sub-study, we 198 
used VA to investigate CoD, which showed that about half (51% based on PCVA and 35% based on 199 
InterVA-4) the deaths were attributed to TB. These findings might be surprising as these were people 200 
accessing health care who had  investigation for TB initiated and who had submitted at least one sputum 201 
specimen for smear microscopy or Xpert MTB/RIF. Though one might hope that people who had TB 202 
investigations initiated should not die of TB, some patients may already been very sick at the time TB 203 
investigation was initiated, as illustrated by the 18.9% with BMI<18.5 and the 64.2% reporting three  or 204 
four  TB symptoms. If these CoD data are correct, it suggests that persons  are  presenting for care too 205 
late, or that the current health system is failing to identify and treat persons who have TB, or both. It 206 
could also be that the health system is too slow to diagnose TB,  resulting in delays in TB treatment 207 
initiation.  This latter possibility was suggested by data from the XTEND trial which showed median time 208 
to starting TB treatment of seven days8 which is a little longer than the Department of Health 209 
recommended two-to-five days 17. HIV-related disease was the second most common CoD, consistent 210 
with absence of ART at enrolment being a risk factor for death among XTEND participants.8  211 
Adults being investigated for TB have been far less studied than those starting TB treatment, and where 212 
CoD data exist, they are generally from hospitals rather than primary health care clinics. The high 213 
proportion of deaths attributable to TB was similar to studies using pathological autopsy to assign CoD. 214 
An autopsy study in South Africa among hospitalised HIV-positive adults either on ART or eligible for 215 
ART, showed that 66% died of TB, while only 27% were on TB treatment at time of death and 33% had 216 
never been treated for TB prior to death.18 In Zambia, a study amongst hospitalised adults, mostly HIV-217 
positive (81%), reported that 62% of deaths were attributed to TB and 26% were never treated for TB 218 
prior to death.19  A recent systematic review among HIV-positive adults and children reported that TB 219 
was a primary cause of death in 91.4% (95% CI 85.5-97) of those diagnosed at autopsy.20 Another study 220 
in South Africa seeking to understand CoD among ART initiators dying in hospital using VA and hospital 221 
case reviews also reported similar findings where mortality attributable to TB was 44.3%.21   222 
Our study compared PCVA and InterVA-4 methods of assigning CoD at individual and population level. 223 
The majority of studies comparing these methodologies have been done in community settings in health 224 
and demographic surveillance system (HDSS) sites where VAs are done for all persons who die. In our 225 
study, when comparing immediate and most probable CoD, PCVA assigned more deaths to TB than 226 
InterVA-4. This could be because InterVA-4 can only assign PTB as a TB related death and assigns EPTB to 227 
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other infectious diseases, while PCVA allows deaths to be assigned as either PTB or EPTB, so EPTB 228 
deaths are not misclassified. PCVA and InterVA-4 models have been compared in other populations and 229 
have shown fair to moderate agreement.22, 23, 24 A study conducted in an HDSS in Kenya, collecting data 230 
on CoD over a six-year period amongst children <5 years and adults aged ≥18 years, showed that PCVA 231 
assigned 9.9% of deaths to PTB and 34% to HIV/AIDS while InterVA assigned 31% to PTB and 16% to 232 
HIV/AIDS (Κ=0.27, 95% CI 0.25-0.30).22 In Ethiopia, data on CoD collected over a 2 year period from 233 
adults aged ≥14 years in an HDSS showed that PCVA assigned 23% to PTB and InterVA-3 assigned 36% 234 
deaths to PTB (Κ=0.5, 95% CI 0.4-0.6).23 When comparing CSMF assigned by PCVA and InterVA, InterVA 235 
assigned more TB than PCVA. This is largely because ICD-10 coding rules require that assignment of 236 
single CoD in individuals with immediate CoD of TB and underlying CoD of HIV be classified as an 237 
HIV/AIDS related death.9 This resulted in 57(81%) of immediate TB deaths assigned at individual level 238 
being classified as HIV/AIDS-related deaths after processing by the MMDS software. A recent study done 239 
in Asia and Africa comparing VA CoD as assigned by PCVA and InterVA-4 also reported a CCC of 0.83 240 
(95% CI 0.75-0.91) between the methods and this was higher than the 0.67 found in our study.25   241 
PCVA assigned more immediate PTB CoD in our study compared to HDSS studies, most likely because 242 
our study included people with symptoms suggestive of TB who were identified by clinic staff as needing 243 
TB investigation. It is also possible that, because the physicians who interpreted the VAs knew that all 244 
study participants were being investigated for TB, this could have biased them to choose TB as a CoD.  245 
A major strength of our study is that our study population was a large systematic sample of adults being 246 
investigated for TB in a real-world setting.  Our results can be generalised to adults being investigated 247 
for TB in similar settings and also to people with TB symptoms severe enough to need investigation.  We 248 
also managed to perform the majority of VA interviews within one year of death which made it easier  249 
for respondents to recall exact events leading to a participant’s death. A study limitation is that we could 250 
not conduct a VA for everyone who died, and could thus have missed other causes of death which has 251 
implications on the profile of causes reported in this population. A higher proportion of decedents who 252 
had VA done had started TB treatment compared to those who died but did not have a VA done. Those 253 
who were on TB treatment would have been easier to contact because they were already in care, 254 
therefore overestimating TB as a CoD in the study.  255 
Our findings show that when interpreting verbal autopsy data using either PCVA or InterVA-4 for adults 256 
being investigated for TB, TB is a leading CoD. These results also suggest that the current TB diagnostic 257 
pathway is inadequate as people with TB disease may still be missed or commenced on treatment too 258 
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late. Thirdly, the fact that HIV was identified as the second most common CoD points to the importance 259 
of integrated TB and HIV care and linkage into care for both diseases. The health service through 260 
implementation science research needs to find ways to facilitate access to TB and HIV care for persons 261 
who need to navigate both services. We recommend that adults being investigated for TB need to be 262 
aware of their HIV status, as data from XTEND also showed that people were more likely to die if they 263 
were HIV positive and not on ART or if their HIV status was unknown 8. Intensified TB screening also 264 
needs to be improved as the sensitivity of the current screening tool is suboptimal and a diagnostic test 265 
for TB with high sensitivity and specificity that could be used in primary health care settings is a priority . 266 
We also recommend that current CCVA methods should be improved so they include EPTB.  Research 267 
has shown that 88% of HIV-positive individuals with autopsy evidence of TB have disseminated disease 268 
20; if VA methods do not classify EPTB as TB, a large number of TB deaths will be missed.  269 
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Table 1:  Characteristics of deceased participants who had verbal autopsy vs those who did not  355 
Variables  Verbal autopsy 
done 
Verbal autopsy 
not done 
P value  
 N=137 N=94  
Characteristics at baseline     
    
Gender, n (%)    
Male 76 (55.4) 57 (60.6) 0.43 
    
Age, years (median, interquartile range) 41 (33-50) 37 (31- 48) 0.14 
    
Country of origin, n (%)*     
South Africa 128 (93.4) 84 (89.4)  
Non-South African  9 (6.5) 9 (9.6) 0.39 
    
Self-reported HIV status at enrolment, n (%)*    
Positive  97 (70.8) 65 (69.1)  
Negative  15 (10.9) 11 (11.7)  
Unknown  25 (18.2) 17 (18.1) 0.98 
    
Self-reported CD4 count (median, 
interquartile range)* 
118 (52-290) 199 (103-253) 0.17 
    
Number of TB symptoms reported at 
enrolment, n (%)* 
   
0 0 (0) 2 (2.1)  
1 15 (10.9) 4 (4.3)  
2 34 (24.8) 16 (17.0)  
3 38 (27.7) 36 (38.3)  
4 50 (36.5) 35 (37.2) 0.05 
    
Body mass index (kg/m2)*    
<18.5 26 (18.9) 22 (23.4)  
18.5-24.9 74 (54.0) 56 (59.5)  
25-29.9 20 (14.6) 8 (8.5)  
30+ 17 (12.4) 7 (7.4) 0.27 
    
HIV and TB treatment initiation, death    
    
Time from enrolment to death, days  
(median, interquartile range)# 
64 (31-115) 57 (28-113) 0.65 
    
Number started on TB treatment, n (%)    
                                            Overall 41(17.7%) 28 (20.4) 13 (13.8) 0.19 
    
14 
 
 Time from enrolment to TB treatment 
initiation, days (median, interquartile 
range) 
11 (7-33) 15 (5-30) 0.94 
    
Number started on ART after enrolment, n=35 
(%) 
23 (65.7) 12 (34.2) 0.50 
    
Time from enrolment to ART initiation, 
days (median, interquartile range) 
25 (9-48) 15 (8-40) 0.30 
    
*Data missing for 1 participant in the group without a verbal autopsy 356 
# data missing for 12 participants  357 
 358 
 359 
  360 
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Table 2:  Immediate cause of death assigned by physician-certified verbal autopsy compared with ‘most 361 
probable’ cause of death assigned by InterVA-4 (n=137) 362 
Cause of death  Physician-certified verbal autopsy  InterVA-4 
 N (%) N (%) 
Pulmonary tuberculosis  
 Not bacteriologically-confirmed 
 Bacteriologically-confirmed 
44 (32.1) 
36 (26.0) 
8 (6.0) 
48 (35.0) 
NA 
NA  
Extrapulmonary tuberculosis  
 Tuberculosis of nervous system 
 Miliary tuberculosis 
              TB of other organs  
26 (19.0) 
11 (8.0) 
10 (7.0) 
5 (4.0) 
NA  
NA  
NA  
NA 
HIV/AIDS-related deaths 21 (15.3) 49 (35.7) 
Gastrointestinal diseases 7 (5.1) 4 (3.0) 
Pneumonia  5 (3.6) 4 (3.0) 
Cardiac disease/ failure 4 (3.0) 5 (3.6) 
Respiratory ailments 4 (3.0) 2 (1.5) 
Renal failure 3 (2.0) 1 (0.7) 
Malignant neoplasm 3 (2.0) 14 (10.2) 
Liver diseases 2 (1.5) 1 (0.7) 
Intentional self-harm/poisoning   2 (1.5) 1 (0.7) 
Meningitis  1 (0.7 ) 0 (0.0) 
Indeterminate/unspecified  4(3.0) 1 (0.7) 
Other  11 (8.0) 7 (5.1) 
Total 137 137 
 363 
 364 
 365 
 366 
 367 
 368 
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Table 3: Comparison of cause specific mortality fractions as assigned by physician certified verbal 369 
autopsy and MMDS and InterVA-4 370 
Cause of death  PCVA CSMF 
% 
InterVA-4 CSMF 
% 
HIV/AIDS related death 66.4 32.8 
Pulmonary tuberculosis 9.5 33.2 
Cardiac diseases  2.9 2.9 
Malignant neoplasm  2.2 9.6 
Gastrointestinal diseases  2.2 0.5 
Accident/self-harm 2.2 0.7 
Diabetes Mellitus  1.5 1.0 
Respiratory ailments  1.5 4.9 
Liver diseases  1.5 1.0 
Other diseases 8.0 6.2 
Unknown cause of death 2.2 7.4 
Total  100 100 
Concordance correlation coefficient: 0.67 (95% CI 0.38 - 0.97) 371 
 372 
  373 
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Table 4:   Agreement between ’most probable’ cause of death assigned by InterVA-4 and single 374 
underlying cause of death assigned by physician-certified verbal autopsy and MMDS for 137 deceased 375 
XTEND participants                        376 
Physician-certified verbal autopsy  
 
 
InterVA-4 
 
 
 
 TB HIV Other Total 
TB 10 32 6 48 
HIV 1 38 10 49 
Other 2 21 17 40 
Total 13 91 33 137 
Cohen’s kappa: 0.20; 95% CI (0.10 - 0.30) 377 
 378 
